TTrialPathMatch Me to Trials
← Back to trials
RecruitingOpioid Use DisorderMajor Depressive Disorder (MDD)

Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation

Eligible age

18–75 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study will compare transcranial magnetic stimulation (TMS) with sham TMS in people with opioid use disorder who are taking buprenorphine and have major depressive disorder with ongoing depressive symptoms. The study will evaluate whether TMS improves depressive symptoms and reduces opioid craving. The study will also assess smoking behaviors, treatment acceptability, and any side effects related to TMS.

Sponsor: University of Kentucky

You may qualify if…

  • ✓ 18-75 years of age
  • ✓ Willing and able to provide informed consent
  • ✓ Able to read and speak english
  • ✓ Opioid use disorder, in remission for at least a month
  • ✓ Diagnosis of major depressive disorder confirmed with the Mini-International Neuropsychiatric Interview (MINI, 7.02)
  • ✓ Minimum score of 10 on the 17-item Hamilton Depression Rating Scale (HDRS-17)
  • ✓ Opioid craving score of 5 or greater on a 0-10 scale
  • ✓ Stabilized on sublingual or depot buprenorphine for at least 8 weeks

You may not qualify if…

  • ✕ Seizure disorder
  • ✕ any other acute medical or behavioral disorder that would preclude safe participation
  • ✕ Pregnant, nursing or planning to become pregnant during the study
  • ✕ Magnetic resonance imaging (MRI) contraindications, including ferrous retainers, intracranial implants, or claustrophobia
  • ✕ Surgical procedure planned during the study period
  • ✕ Any other medical condition that could compromise participant well-being

Where it's recruiting

Kentucky

Lexington

Source: ClinicalTrials.gov · NCT07842601 · last updated 2026-11-17